I am a
Home I AM A Search Login

Papers of the Week

2022 Feb

Ann Transl Med



Adverse events of different PD-1 inhibitors in lung cancer patients: a real-world study.


Zheng X, Tao G, Sun S, Jin X, Chen Y, Zhang Y, Sun J, Huang P
Ann Transl Med. 2022 Feb; 10(4):183.
PMID: 35280395.


Programmed death-1 (PD-1) inhibitors have been approved and are currently widely used to treat lung cancer patients. However, comparative data on the adverse events (AEs) associated with different PD-1 inhibitors are very limited.